Tocilizumab for induction and maintenance of remission in giant cell arteritis: a phase 2, randomised, double-blind, placebo-controlled trial.
Villiger P.M., Adler S., Kuchen S., Wermelinger F., Dan D., Fiege V., Bütikofer L., Seitz M., Reichenbach S., 2016/05/07. Lancet, 387 (10031) pp. 1921-1927. Peer-reviewed.
ici le détail